Immuno-oncology – Five Tactics to Enhance your Drug Development Strategy

As an immuno-oncology drug developer, you have the opportunity to dramatically improve patients’ lives. However, to succeed in this risky venture you need to overcome a number of complex challenges, such as the need to encourage more potent antigenic stimulation and improve T cell access to the tumour.